Sunshine Heart announces FDA approves key protocol amendment for COUNTER HF(TM)
Sunshine Heart announced the FDA has approved an amendment to the stopping rule criteria for the Company's COUNTER HF™ pivotal study for its C-Pulse Heart Assist System®. The Agency has agreed to change this protocol from "all cause" deaths to specifically, mortality associated with device. August 31, 2015